PharmaShots Weekly Snapshots (January 08 – January 12, 2024)

Share this

PharmaShots Weekly Snapshots (January 08 – January 12, 2024)

This week PharmaShots’ news was all about the updates on M&A, Pharma, Clinical Trials, Regulatory & MedTech. Check out our full report below:


The US FDA Approved Ligand Pharmaceuticals’ Zelsuvmi for the Treatment of Molluscum Contagiosum

Read More: Ligand Pharmaceuticals                                                                                               

The European Commission Approved UCB’s Rystiggo (rozanolixizumab) to Treat Adults with Generalized Myasthenia Gravis (gMG)

Read More: UCB                                                                                                                              

 The US FDA has Accepted the IND Application of Caliway’s CBL-514 for Dercum’s Disease

Read More: Caliway Biopharmaceuticals  

The NMPA Approves Eisai and Biogen’s Leqembi (Lecanemab) for the Treatment of Alzheimer’s Disease

Read More: Eisai & Biogen                                                                                                                 

The US FDA Accepts Pfizer’s sBLA for Tivdak for Priority Review to Treat Cervical Cancer 

Read More: Pfizer                                                                                                                        

The NMPA approves GSK’s Nucala (mepolizumab) for the Treatment of Severe Eosinophilic Asthma

Read More: GSK                                                                                                                         

The US FDA Accepts HUTCHMED’s NDA for Sovleplenib and Grants Priority Review for the Treatment of Primary Immune Thrombocytopenia (PIT)

Read More: HUTCHMED                                                                                                                        

China’s NMPA Grants IND Approval to Fermion’s FZ008-145 for Pain Relief 

Read More: Fermion                                                                                                                              

The EC Grants Conditional Marketing Authoriztaion to Mirati Therapeutics’ Krazati (adagrasib) for Advanced Non-Small Cell Lung Cancer (NSCLC) 

Read More: Mirati Therapeutics                                                                                                             

RemeGen's RC88 Receives FTD from the US FDA for the Treatment of Ovarian Cancer 

Read More: RemeGen                                                                                                               


SanReno Therapeutics Reports Acquisition by Novartis for the Advancement of Transformative Medicines for Kidney Disease

Read More: Novartis & SanReno Therapeutics                                                                                  

For an Aggregate of ~$2.0B, Johnson & Johnson to Acquire Ambrx Biopharma

Read More: Johnson & Johnson & Ambrx Biopharma                                                                    

For an Aggregate of $680M, Merck & Co. to Acquire Harpoon Therapeutics

Read More: Merck & Co. & Harpoon Therapeutics                                                                      

For an Aggregate of ~$1.4B, GSK to Acquire Aiolos Bio 

Read More: GSK & Aiolos Bio                                                                                               

Galvanize Therapeutics Reports Acquisition of its Electrophysiology Technology Division by CardioFocus 

Read More: CardioFocus & Galvanize Therapeutics                                                                      


Merck Initiates a Series of P-III Trials for Bomedemstat, Nemtabrutinib, MK-2870 and MK-5684 to Treat Solid Tumors

Read More: Merck                                                                                                                     

Novartis Highlights the P-III Results for Scemblix (asciminib) to Treat Newly Diagnosed Chronic Myeloid Leukemia

Read More: Novartis                                                                                                                      

Innovent Highlight the P-III Results for Mazdutide (IBI362) to Treat Adults with Overweight or Obesity

Read More: Innovent                                                                                                                    

Alcon Highlights the P-III Results for AR-15512 to Treat Dry Eye Disease

Read More: Alcon                                                                                                                

SELLAS Highlights Updated Data from its P-IIa Study of SLS009 for R/R Acute Myeloid Leukemia (AML)

Read More: SELLAS Life Sciences                                                                                    

bridgebio Highlights the P-III Results for Acoramidis to Treat Transthyretin Amyloid Cardiomyopathy

Read More: bridgebio                                                                                                                  

Renovion Reports Completion of Patient Recruitment in the P-II (CLIMB) Study of ARINA-1 for Bronchiectasis

Read More: Renovion                                                                                                               


Medison Pharma Sings an Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo (cemiplimab) Globally for Cancer Treatment

Read More: Medison Pharma & Regeneron Pharmaceuticals                                                         

ConcertAI and Caris Life Sciences Sign a Collaboration Agreement with AbbVie to Enhance Research and Development Efforts Towards Cancer Treatment

Read More: ConcertAI, Caris Life Sciences & AbbVie                                                                   

Henlius Partners with Sermonix to Develop Lasofoxifene for Breast Cancer

Read More: Henlius & Sermonix                                                                                    

SyntheticGestalt Partners with Enamine to Create AI-Based Model for Drug Discovery

Read More: Xcell Biosciences & ElevateBio                                                                             

Xcell Biosciences Collaborates with ElevateBio to Develop Technology for Cell and Gene Therapies

Read More: SyntheticGestalt & Enamine                                                                      


Transforming Women's Health with Technology: The US FDA Approves Qvin’s Q-Pad Kit to Track Diabetes Using Menstrual Sample Testing 

Read More: Qvin                                                                                                         


Ultromics Signs a a Collaboration Agreement with Pfizer to Enhance the Development of EchoGo for the Detection of Cardiac Amyloidosis

Read More: Ultromics & Pfizer                                                                                                

The US FDA Grants IDE Approval to Endovascular Engineering’s Hēlo Thrombectomy System for Pulmonary Embolism

Read More: Endovascular Engineering                     

Related Post:- PharmaShots Weekly Snapshots (January 01 – January 05, 2023)                                                                      

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions